SF-1 overexpression in childhood adrenocortical tumours
- PMID: 16574405
- DOI: 10.1016/j.ejca.2006.01.022
SF-1 overexpression in childhood adrenocortical tumours
Abstract
The steroidogenic factor 1 (SF-1) gene encodes a transcription factor playing a pivotal role in the regulation of adrenogenital development. We have recently shown that SF-1 is amplified in childhood adrenocortical tumours (ACT). This study was aimed to assess if an increase in SF-1 gene copy number was associated with increased protein levels and to study the correlation between SF-1 expression and ACT clinical parameters. An increased SF-1 copy number was detected in eight of the 10 ACT cases studied. Conversely, the SF-1 protein was found to be overexpressed in all cases, compared to normal age-matched adrenal glands. No significant correlation was found between SF-1 protein levels and its gene copy number. Furthermore, no significant correlation existed with histological grade or with the clinical manifestation or evolution of disease. This data show that SF-1 overexpression is widespread in childhood ACT and is likely to play a role in its pathogenesis.
Similar articles
-
Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.Mol Cell Endocrinol. 2005 Apr 15;233(1-2):47-56. doi: 10.1016/j.mce.2005.01.012. Mol Cell Endocrinol. 2005. PMID: 15767045
-
Role of transcription factors Ad4bp/SF-1 and DAX-1 in steroidogenesis and spermatogenesis in human testicular development and idiopathic azoospermia.Int J Urol. 2006 Jun;13(6):785-93. doi: 10.1111/j.1442-2042.2006.01403.x. Int J Urol. 2006. PMID: 16834661
-
Transcriptional regulation of human Oct4 by steroidogenic factor-1.J Cell Biochem. 2007 Aug 1;101(5):1198-209. doi: 10.1002/jcb.21244. J Cell Biochem. 2007. PMID: 17226773
-
The molecular pathogenesis of childhood adrenocortical tumors.Horm Metab Res. 2007 Jun;39(6):461-6. doi: 10.1055/s-2007-981476. Horm Metab Res. 2007. PMID: 17578765 Review.
-
Adrenocortical development and cancer: focus on SF-1.J Mol Endocrinol. 2010 Jun;44(6):301-7. doi: 10.1677/JME-09-0143. Epub 2010 Mar 3. J Mol Endocrinol. 2010. PMID: 20200142 Review.
Cited by
-
Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation.Oncotarget. 2016 Nov 29;7(48):79292-79304. doi: 10.18632/oncotarget.12685. Oncotarget. 2016. PMID: 27764813 Free PMC article.
-
Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art.J Oncol. 2012;2012:234726. doi: 10.1155/2012/234726. Epub 2012 Oct 18. J Oncol. 2012. PMID: 23125857 Free PMC article.
-
SF-1 deficiency causes lipid accumulation in Leydig cells via suppression of STAR and CYP11A1.Endocrine. 2016 Nov;54(2):484-496. doi: 10.1007/s12020-016-1043-1. Epub 2016 Jul 25. Endocrine. 2016. PMID: 27455990
-
Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia.Front Oncol. 2022 Jan 20;11:779859. doi: 10.3389/fonc.2021.779859. eCollection 2021. Front Oncol. 2022. PMID: 35127484 Free PMC article.
-
Steroidogenic Factor 1 (NR5A1) Activates ATF3 Transcriptional Activity.Int J Mol Sci. 2020 Feb 20;21(4):1429. doi: 10.3390/ijms21041429. Int J Mol Sci. 2020. PMID: 32093223 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources